Seeking Alpha / - 23 hours ago
In this free webinar, gain insight into the FDA's perspective on model-informed drug development (MIDD). Attendees will learn about pharmacokinetic/pharmacodynamic (PK/PD) modeling strategies and their benefits. The featured speakers will discuss the application of PK/PD modeling and...
Seeking Alpha / - 23 hours ago
In this free webinar, learn about the importance of moving beyond BMI to incorporate a range of biomarkers in clinical trials for obesity to enhance the accuracy of obesity diagnosis, facilitate precision medicine and improve the prevention and treatment of obesity-related diseases. The...
Seeking Alpha / - 23 hours ago
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, drug discovery & development and laboratory technology. TORONTO , July 3, 2025 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in...
Seeking Alpha / - 23 hours ago
FORM 8.5 (EPT/RI)
Seeking Alpha / - 23 hours ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between October 31, 2024 and April 30, 2025 and would like to...
Seeking Alpha / - 23 hours ago
ORANGE COUNTY, Calif., July 3, 2025 /PRNewswire/ -- The Little Red Dog, a non-profit dog rescue, announced today its July fundraiser, a critical social media-driven campaign to combat surging euthanasia rates and dwindling donations. The organization is issuing an urgent call to action:...
Seeking Alpha / - 23 hours ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Civitas To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Civitas between February 27, 2024 and February 24, 2025 and would like to...
Seeking Alpha / - 23 hours ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Compass To Contact Him Directly To Discuss Their Options If you suffered purchased or acquired securities in Compass stock or options between May 1, 2024 and May 7, 2025 and...
Seeking Alpha / - 23 hours ago
GOTHENBURG, Sweden, July 3, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q2 2025 interim report on Thursday, 17 July 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day. The presentation will be held...